PMID: 7544197May 1, 1995Paper

Subtypes of tachykinin receptors on tonic and phasic neurones in coeliac ganglion of the guinea-pig

British Journal of Pharmacology
F Y ZhaoM Otsuka

Abstract

1. Intracellular recording techniques were used to investigate the characteristics of tachykinin receptors and their subtypes in tonic and phasic neurones, which constituted two major neuronal populations in the coeliac ganglion of the guinea-pig. 2. In 95% of phasic neurones a long-lasting after-hyperpolarization (LAH), 5-8 s in duration and 10-20 mV in amplitude, was observed following action potentials evoked by passing a train of depolarizing current pulses into the neurones. In contrast, LAH was observed in only 4% of tonic neurones. 3. In most tonic neurones, substance P (SP), neurokinin A (NKA) and senktide induced depolarizations, whereas in phasic neurones they usually inhibited LAH but rarely induced depolarization. 4. Tonic and phasic neurones were further classified into three groups based on their responses (depolarization for tonic neurones and LAH inhibition for phasic neurones) to these tachykinin receptor agonists: (1) neurones responsive to SP, NKA and senktide (71-78%); (2) those responsive to senktide but not to SP and NKA (12-23%) and (3) those not responsive to any of the three agonists (7-11%). 5. GR71251 (5 microM), an NK1-selective tachykinin receptor antagonist, depressed the depolarization in tonic ne...Continue Reading

References

Dec 1, 1992·Trends in Neurosciences·W Jänig, E M McLachlan
Jul 1, 1990·Journal of Medicinal Chemistry·P WardJ R Brown
Nov 1, 1987·Pain·D Papir-KricheliM Devor
Apr 1, 1993·Physiological Reviews·M Otsuka, K Yoshioka
Jan 1, 1994·Journal of Ocular Pharmacology·C E CrossonJ M Gidday

❮ Previous
Next ❯

Citations

Sep 16, 2000·European Journal of Pharmacology·F F Lam, A L Yip
Nov 8, 2001·European Journal of Pharmacology·R Patacchini, C A Maggi
Jul 16, 1997·European Journal of Pharmacology·T S SalehY S Medeiros
Jul 4, 1998·European Journal of Pharmacology·M K Hahn, M J Bannon
Dec 1, 1998·European Journal of Pharmacology·J E ThorbøllE Skadhauge
Aug 8, 1998·Journal of the Autonomic Nervous System·J P Messenger, I L Gibbins
Feb 17, 2001·Regulatory Peptides·J Yip, L A Chahl
Mar 26, 2003·Brain Research. Molecular Brain Research·Sarah J BakerIan L Gibbins
Jul 15, 1998·Peptides·G G Nussdorfer, L K Malendowicz
Oct 9, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Rafaela L Ribeiro, Thereza C M De Lima
Oct 30, 2003·Neuroscience Letters·Geneviève-Anne Gaudreau, Victor Plourde
Aug 1, 1996·British Journal of Pharmacology·F Y ZhaoM Otsuka
Jul 9, 1998·American Journal of Respiratory and Critical Care Medicine·S DaouiC Advenier
Mar 1, 2008·The Journal of Physiology·Craig Blomeley, Enrico Bracci
Aug 28, 1999·The Journal of Comparative Neurology·J P MessengerI L Gibbins
Mar 18, 2006·The Journal of Physiology·X MaM W Chapleau
Jan 12, 2020·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marina GerguesPranela Rameshwar
Jul 23, 2003·British Journal of Pharmacology·Chiara DianzaniRoberto Fantozzi
Mar 14, 2007·British Journal of Pharmacology·H Karmouty-QuintanaN Beckmann
Sep 11, 2017·Biophysics Reviews·Eder Ricardo de MoraesLígia Araujo Naves
Jan 25, 2006·British Journal of Pharmacology·Margherita GallicchioRoberto Fantozzi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.